Wikidata

(Q39115085)

English

In vivo activating transcription factor 3 silencing ameliorates the AMPK compensatory effects for ER stress-mediated β-cell dysfunction during the progression of type-2 diabetes.

scientific article published on 2 August 2013

In more languages
default for all languages
No label defined

No description defined

Statements

title
In vivo activating transcription factor 3 silencing ameliorates the AMPK compensatory effects for ER stress-mediated β-cell dysfunction during the progression of type-2 diabetes (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23916985
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23916985%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 March 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39115085&oldid=1813763050"